Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone hydrogel for post-lung transplant atrial fibrillation
NCT03221764Phase 2Completed
- Sponsor
- University of Louisville
- Start
- Oct 2017
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by University of Louisville. Primary endpoint: Post Operative Atrial Fibrillation at 1 year. Started Oct 2017; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03221764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03221764.